Tempus AI, Inc

Rentabilité sur six mois: +3.42%
Rendement en dividendes: 0%

71.32 $

+0.04 $ +0.0561%
31.83 $
89.44 $

paper.min_max_per_year

Calendrier des promotions Tempus AI, Inc

À propos de l'entreprise Tempus AI, Inc

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.

Paramètres de base

IPO date
2024-06-14
ISIN
US88023B1035
Industry
Life Sciences Tools & Services
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 5.84 2
P/BV 71.82 1
P/E 0 0
Efficacité
Nom Signification Grade
ROA -94.73 0
ROE 106.47 10
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.7668 10
Debt/Ratio 0.5054 9
Debt/Equity 15.44 0
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 268.83 10
Rentabilité Ebitda, % 257.22 10
Rentabilité EPS, % 362.58 10

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 71.28 $ 0 $ 0 $ +0.0561 % 0 % 0 %
common.calendar.number_days.7d 70.78 $ 0 $ 0 $ +0.7629 % 0 % 0 %
common.calendar.number_days.30d 62.56 $ 71.28 $ 71.32 $ +14 % 0 % 0 %
common.calendar.number_days.90d 42.12 $ 40.45 $ 71.32 $ +69.33 % 0 % 0 %
common.calendar.number_days.180d 68.96 $ 34.75 $ 89.44 $ +3.42 % 0 % 0 %
common.calendar.number_days.1y 59.23 $ 31.83 $ 89.44 $ +20.41 % 0 % 0 %
common.calendar.number_days.3y 24.96 $ 24.96 $ 89.44 $ +285.58 % 0 % 0 %
common.calendar.number_days.5y 24.96 $ 24.96 $ 89.44 $ +285.58 % 0 % 0 %
common.calendar.number_days.10y 24.96 $ 24.96 $ 89.44 $ +285.58 % 0 % 0 %
common.calendar.number_days.ytd 50.77 $ 31.83 $ 89.44 $ +40.48 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Eric P. Lefkofsky Co-Founder, CEO, President & Chairman 1970 (55 années)
Mr. James Rogers Chief Financial Officer 1986 (39 années)
Mr. Ryan Fukushima Chief Operating Officer 1985 (40 années)
Mr. Ryan M. Bartolucci Chief Accounting Officer 1982 (43 année)
Mr. Shane Colley Chief Technology Officer
Dr. Kate A. Sasser Ph.D. Chief Scientific Officer 1977 (48 années)
Mr. Erik Phelps Executive VP, Assistant Secretary and Chief Administrative & Legal Officer 1971 (54 année)
Ms. Patty Spiller Senior Vice President of Marketing
Ms. Christina Antoniou Senior VP & Head of Corporate Development
Ms. Stacey Kraft Chief People Officer

Informations sur l'entreprise

Adresse: United States, Chicago, 600 West Chicago Avenue - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.tempus.com